Dividend stocks can offer significant returns or passive income. Two notable options for investment are Pfizer and Realty Income.
Pfizer, trading at around $30 per share with a dividend yield of 6.6%, has shown resilience despite challenges during the pandemic. The company increased its dividend annually for 16 years and is poised to benefit from future acquisitions in biotech and pharma sectors. Their revenue growth normalized post-pandemic, and they aim to introduce more blockbuster drugs by early 2030s.
Realty Income, a real estate trust with a consistent 5.8% dividend yield, stands out for its long-standing dividend history of over 55 years. With a diverse portfolio across various industries, the company provides stable income through triple net leases. Their tenant base includes well-known retailers and grocery chains, ensuring steady revenue growth despite market challenges.
Both stocks offer attractive returns and stability, making them strong candidates for investors seeking consistent dividends in 2025.**
Source: https://www.fool.com/investing/2025/01/26/have-500-2-high-yield-dividend-stocks-to-buy-right